There has been a major interest in the drug treatment of osteoporosis and an increase in the
number of drugs available in most countries. The ideal drug (one which increases or …

Osteoporosis is a “systemic skeletal disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility …

The goals of treatment for patients with osteoporosis are to maintain normal bone and to
prevent the deterioration of normal bone to osteoporotic bone. Achievement of these goals …

Substantial progress has been made in the past several years in the understanding and
modification of osteoporosis management. Many conditions encountered by rheumatologists …

Rheumatoid arthritis is associated with both localized and generalized osteoporosis.
Localized osteoporosis can be considered to be caused by local disease mechanisms …

Recently, the field of metabolic bone disease has received prominent recognition because
of the increased public awareness of the prevalence and problems associated with …

Osteoporosis is a common, chronic, and costly condition. Both the incidence and costs of
osteoporosis-related complications are expected to increase by 50% over the next 2 …

Osteoporosis as a common chronic disease is challenging human health. Although different
therapeutic options are routinely used for prevention/treatment of osteoporosis, their side …

PREVIEW Because osteoporosis management is a rapidly changing landscape, primary
care physicians may not know what to tell their female patients about the best choice of …

Osteoporosis is common among postmenopausal women. Unfortunately, in the past it was
frequently regarded by clinicians as a normal part of aging, with little need for therapeutic …